Latest Bladder Cancer News
An interview with David J. McConkey, PhD
Four key lifestyle factors include weight, exercise, no smoking, and limiting alcohol.
Atezolizumab received accelerated FDA approval for patients whose disease has progressed despite platinum-based chemotherapy.
Findings for self-reported leisure-time physical activity of moderate to vigorous intensity.
In a meta-analysis, men with benign prostatic hyperplasia had a 2.9 times and 1.7 times increased incidence of prostate cancer and bladder cancer, respectively.
Bladder cancer risk increases with longer duration of use.
Researchers found elevated incidences of upper tract urothelial carcinoma (UTUC) in patients with CKD.
Patients who underwent debulking had significantly longer overall survival compared with those who did not (median 15.7 vs 10 months).
Therapy used in less than 5% of cases, even in those with higher clinical stage.
Mortality risk decreases with increasingly stringent BPT compared with radical cystectomy.
African American survivors had lower intakes of 8 select micronutrients, such as folate, compared with Caucasian survivors.
This approach is associated with less need for blood transfusions versus open surgery, but short-term outcomes, including mortality, are similar.
The increased risk occurs more than 10 years after treatment and most pronounced in men who undergo brachytherapy.
Cancer-specific survival at 5 years was 76.9% for men and 71.5% for women.
New study also reveals no significant association between infection and use of proton pump inhibitors and peri-operative antibiotic redosing.
Researchers believe arsenic exposure might contribute to higher-than-normal rates.
Bladder Cancer Videos
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)